Dr. Sohail A. Minhas, MD

Dr. Minhas practices at Baptist Memorial Hospital-Union County in New Albany, Mississippi, part of Baptist Memorial Health Care.

Dr. Minhas' NPI, 1053303750, was assigned on August 18, 2005. Dr. Minhas graduated from Rawalpindi Medical College in 1985. Dr. Minhas holds Mississippi license 16334.

Dr. Minhas' primary practice is Baptist Memorial Hospital-Union County, at 200 Hwy 30 West, New Albany, MS 38652 in Union County. The practice phone is (662) 538-7631.

Dr. Minhas' primary practice is Baptist Memorial Hospital-Union County in New Albany, Mississippi, part of Baptist Memorial Health Care. Dr. Minhas is also affiliated with Baptist Memorial Hospital-Memphis. The medical group on file is Baptist Medical Group. Dmand AI also links Dr. Minhas to 2 more hospitals, 5 medical groups, 3 group practices and clinics and 2 home health agencies, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Minhas practices, 9 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Minhas' primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Minhas is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Minhas' licenses on file in 3 states: Mississippi, Arkansas and Tennessee.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), fluid and electrolyte imbalances and immune deficiency disease among the conditions Dr. Minhas treats.

CMS data shows 1,597 Medicare services from Dr. Minhas across 11 procedure codes in 2024, for 410 Medicare patients. Medicare paid $97,122 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 410 Medicare patients who saw Dr. Minhas in 2024. The largest group is 75 to 84, with 160 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 2.03, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Minhas' median patient age at 74, with 62% women.

In 2024, Dr. Minhas wrote 1,736 Medicare Part D claims for 223 patients. 83% of them were for generic drugs. CMS names the drug for 1,478 of them, across 46 drugs with 11 or more claims each, at $2,442,779 in total drug cost. In 2023, CMS named 1,285 claims across 42 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Minhas for performance year 2024, reported as part of a group. Dr. Minhas accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Minhas as offering telehealth.

Dmand AI links 2 papers to Dr. Minhas in 2021. 2021 was the busiest year, with 2. Dr. Minhas has published most often in Cureus.

Dmand AI links Dr. Minhas to 2 clinical trials. Conditions studied include Gallbladder Neoplasms and Gallbladder Diseases.

CMS Open Payments shows 1,310 general payments to Dr. Minhas from 77 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 68% of the total. AstraZeneca Pharmaceuticals LP paid the most, $5,928.

Dr. Minhas graduated from Rawalpindi Medical College in 1985. Dr. Minhas is a member of ASCO.

Dr. Minhas is in network with 16 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.